Author: BusinessWire

Martin, MD, and Helman, MD, Leading Firm’s Biotech, Pharma, and Medtech Consulting Practice; Resnick Joins to Oversee Regional Growth Strategy Teams
WASHINGTON–(BUSINESS WIRE)–Guidehouse, a leading global provider of consulting services to the publi…

FALL RIVER, Mass.–(BUSINESS WIRE)–Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, announced today the addition of an extra-small shipper to its TRUEtemp Natu…

SEATTLE–(BUSINESS WIRE)–#OligoSynthesis–According to Coherent Market Insights the global oligonucleotide synthesis market is estimated to be valued at US$ 2,874.1 Million in 2020, and is expected to exhibit a CAGR of 11.3% during the forecast period…

FALL RIVER, Mass.–(BUSINESS WIRE)–Packaging Technology Group, Inc (PTG), a leading provider of thermal packaging solutions for the biopharmaceutical and life sciences sector, announced today the addition of an extra-small shipper to its TRUEtemp Natu…

SEATTLE–(BUSINESS WIRE)–#OligoSynthesis–According to Coherent Market Insights the global oligonucleotide synthesis market is estimated to be valued at US$ 2,874.1 Million in 2020, and is expected to exhibit a CAGR of 11.3% during the forecast period…

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will p…

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will p…

SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…